| Literature DB >> 28879090 |
Rajesh Shankar Iyer1, T C R Ramakrishnan1, Ajit Shinto2, Koramadai Karuppuswamy Kamaleshwaran2.
Abstract
•Faciobrachial dystonic seizures (FBDS) are caused by autoantibodies to leucine-rich glioma-inactivated1 proteins, a component of the voltage-gated potassium channel complex (VGKC-complex) and precede the clinical presentation of limbic encephalitis.•The exact pathophysiology of FBDS is not known and whether they are seizures or movement disorder is still debated.•We suggest the fronto-temporo-basal ganglia network involving the medial frontal and temporal regions along with the corpus striatum and substantia nigra being responsible for the clinical phenomenon of FBDS.•The varied clinical, electrical and imaging features of FBDS in our cases and in the literature are best explained by involvement of this network.•Entrainment from any part of this network will result in similar clinical expression of FBDS, whereas other electro-clinical associations and duration depends on the extent of involvement of the network.Entities:
Keywords: Basalganglial hypermetabolism; Faciobrachial dystonic seizures; Fronto–temporo–basalganglial network; LGI1antibody; Network hypothesis; VGKC antibody encephalitis
Year: 2017 PMID: 28879090 PMCID: PMC5573798 DOI: 10.1016/j.ebcr.2017.06.001
Source DB: PubMed Journal: Epilepsy Behav Case Rep ISSN: 2213-3232
Fig. 1MRI Brain FLAIR images axial (A) and sagittal (B) of patient 1 showed bilateral medial temporal hyperintensities. MRI FLAIR images axial (C) in two months, follow-up showed diffuse brain atrophy and persistence of medial temporal hyperintensities. PET CT Brain at presentation (D) showed bilateral basal ganglial and amygdalar hypermetabolism. PET CT Brain at two-month follow-up (E) showed bilateral basal ganglial hypermetabolism and disappearance of medial temporal hypermetabolism. Ictal EEG (F,G) showed movement artifacts with the jerk followed by brief attenuation and build-up of right temporal spikes. MRI Brain axial images T2 (H), FLAIR (I) and T1 (J) in patient 2 showed basal ganglia hyperintensities. T2 axial images (K) also showed left sided substantia nigra hyperintensity (white arrow).
Current literature on the pathophysiology of FBDS.
| Article | Pt no: | Sz vs MD | EEG | MRI | PET/SPECT | Discussion |
|---|---|---|---|---|---|---|
| Irani et al., 2008 | 3 | Extratemporal | movement artifact followed by left fronto–temporal theta in pt. 1, normal in pt. 2, temporal lobe sz in pt. 3 | BG abn in pt1, normal in pt. 2, b/l HC abn in pt3 | – | likely extra temporal seizures. Non-epileptic generators to be considered |
| Barajas et al.,2010 | 1 | Sz | temporal lobe seizures | Frontal and HC abn | – | unsure about the pathophysiology of jerks before sz |
| Irani et al., 2011 | 29 | FBDS are frontal Sz, temporal sz only after development of LE | Ictal changes in 7(24%) | Normal during FBDS | PET abn in 6 of 8 in temporal, 5 of 8 in BG | Likely sz since, |
| Striano et al., 2011 | – | Hemidystonia | – | – | – | Unlikely to be Sz since |
| Andrade et al., 2011 | 3 | Tonic Sz | Ictal EDP before dystonic events | HC atrophy in 2 normal in 1 | – | Ictal EDP suggests remote sz origin from interhemispheric frontal region. Subclinical TNC Sz in all |
| Boesebeck et al., 2013 | 1 | Features of both sz and movement disorder | Normal | BG and medial frontal abn | BG hypermetabolism | FBDS originate from cortical and subcortical areas |
| Flanagan et al., 2015 | 26 | – | Ictal EEG (23) normal in 20 and 3 had temporal sz | BG and TL changes in 11 of 26 each (42%) | PET in 14 BG changes in 6 and TL changes in 3, diffuse in 3 and bifrontal in 2 | BG abn exclusive to pts. with FBDS, c/l to the side of FBDS. BG are the sites of origin of FBDS. |
No = number; Sz = seizure; MD = movement disorder; Pt = patient; BG = basal ganglia; b/l = bilateral; c/l = contralateral; abn = abnormalities; HC = hippocampus; LE = limbic encephalitis; LOC = loss of consciousness; IEC = ictal EEG changes; EDP = electro-decremental pattern; TNC = Temporal neocortical; TL = temporal lobe; AED = anti-epileptic drugs.
Fig. 2Schematic diagram showing the fronto–temporo–basal ganglia network (dotted line).